Adage Capital Partners
OCUL icon

Adage Capital Partners’s Ocular Therapeutix OCUL Stock Holding History

Adage Capital Partners’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,625,050
Closed -$56.1M – 1041
2025
Q4 		$56.1M Buy
4,625,050
+620,700
+16% +$7.54M 0.09% 227
2025
Q3 		$46.8M Buy
4,004,350
+114,173
+3% +$1.37M 0.07% 251
2025
Q2 		$36.1M Sell
3,890,177
-1,309,823
-25% -$10.3M 0.06% 306
2025
Q1 		$38.1M Buy
5,200,000
+1,600,000
+44% +$12.3M 0.07% 288
2024
Q4 		$30.7M Sell
3,600,000
-150,000
-4% -$1.46M 0.05% 320
2024
Q3 		$32.6M Buy
3,750,000
+54,953
+1% +$453K 0.06% 318
2024
Q2 		$25.3M Buy
3,695,047
+3,320,047
+885% +$20.5M 0.05% 376
2024
Q1 		$3.41M Buy
+375,000
New +$2.66M 0.01% 737

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return